HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Men's Health


The Endocrinology Network ® Men’s Health clinical resource center highlights disparities in the care and identification of multiple medical conditions impacting men. Additionally, the resource center will feature content related to reproductive issues, hormone therapy, and more in the form of articles, videos, and podcasts.

GnRH Agonists for Prostate Cancer Could Increase CVD Risk in Type 2 Diabetes

August 09, 2022

New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.

TLANDO, an Oral Option for TRT for Men, Approved by US FDA

March 29, 2022

On March 29, Antares Pharma announced the FDA granted approval to their oral testosterone replacement therapy option, testosterone udecanoate (TLANDO), for conditions associated with a deficiency or absence of endogenous testosterone or hypogonadism in adult males.

Increased Oxytocin Levels Could Be Driving Hypersexual Disorder in Men

February 03, 2022

New research suggests men with hypersexual disorder had increased plasma oxytocin levels and indicate cognitive-behavioral therapy was associated with a decrease in these levels as well as symptoms of hypersexual disorder.

COVID-19 Vaccines Do Not Impact Male Fertility, Study Finds

June 22, 2021

A recent study from the University of Miami suggests the Moderna and Pfizer COVID-19 vaccines were not associated with reductions in any sperm parameters, including semen volume, sperm concentration, sperm motility, and total motile sperm count.